Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: Experience from the Stockholm health care system

International Journal of Cardiology

Volumn 170, Issue 2, 2013, Pages 208-214

  Forslund, Tomas ^a   Wettermark, Björn ^b   Wändell, Per ^c   Von Euler, Mia ^c   Hasselström, Jan ^c   Hjemdahl, Paul ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Network for Pharmacoepidemiology Foundation   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticoagulant treatment; Atrial fibrillation; Cardiology; Primary care; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR RISK; CHA2DS2VASC SCORE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VERY ELDERLY; VISUAL ANALOG SCALE; YOUNG ADULT;

ANTICOAGULANT TREATMENT; ATRIAL FIBRILLATION; CARDIOLOGY; CHA(2)DS(2)VASC; PRIMARY CARE; WARFARIN;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRIMARY HEALTH CARE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; THROMBOSIS; WARFARIN; YOUNG ADULT;

EID: 84889101086     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.063     Document Type: Article

References (29)

1. L. Friberg, and L. Bergfeldt Atrial fibrillation prevalence revisited J Intern Med 274 5 Nov 2013 461 468
2. A.J. Camm, G.Y. Lip, and R. De Caterina ESC Committee for Practice Guidelines (CPG); 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 21 Nov 2012 2719 2747
3. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
4. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 33 12 Jun 2012 1500 1510
5. 2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish diet, cancer, and health cohort study Circ Cardiovasc Qual Outcomes 5 3 May 1 2012 335 342
6. J.B. Olesen, G.Y. Lip, and M.L. Hansen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 Jan 31 2011 d124
7. J.B. Olesen, G.Y. Lip, and J. Lindhardsen Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 106 2011 739 749
8. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 19 May 15 2012 2298 2307
9. M. Coppens, J.W. Eikelboom, and R.G. Hart The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Eur Heart J 34 3 Jan 2013 170 176
10. L. Friberg, N. Hammar, M. Ring, H. Pettersson, and M. Rosenqvist Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Eur Heart J 27 2006 1954 1964
11. G.H. Nilsson, I. Björholt, and H. Johnsson Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population BMC Fam Pract 4 2003 3
12. G.H. Nilsson, I. Björholt, and I. Krakau Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden - a retrospective study of incidence and quality in a registered population Fam Pract 21 2004 612 616
13. A.C. Carlsson, P. Wändell, K. Sundquist, S.E. Johansson, and J. Sundquist Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007 Eur J Clin Pharmacol 69 2 Feb 2013 245 253
14. R.K. Sandhu, J.A. Bakal, J.A. Ezekowitz, and F.A. McAlister The epidemiology of atrial fibrillation in adults depends on locale of diagnosis Am Heart J 161 5 May 2011 986-992.e1
15. T. Meinertz, W. Kirch, L. Rosin, D. Pittrow, S.N. Willich, and P. Kirchhof ATRIUM investigators. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry Clin Res Cardiol 100 10 Oct 2011 897 905
16. A.B. Wiréhn, H.M. Karlsson, and J.M. Carstensen Estimating disease prevalence using a population-based administrative healthcare database Scand J Public Health 35 4 2007 424 431
17. J. Ludvigsson, P. Otterblad-Olausson, B.U. Pettersson, and A. Ekbom The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research Eur J Epidemiol 24 2009 659 667
18. J.F. Ludvigsson, E. Andersson, and A. Ekbom External review and validation of the Swedish national inpatient register BMC Public Health 11 Jun 9 2011 450
19. J.G. Smith, P.G. Platonov, B. Hedblad, G. Engstrom, and O. Melander Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity Eur J Epidemiol 25 2010 95 102
20. A.C. Nilsson, C.L. Spetz, K. Carsjo, R. Nightingale, and B. Smedby Reliability of the hospital registry. The diagnostic data are better than their reputation Lakartidningen 91 1994 [598,603605]
21. E. Ingelsson, J. Arnlov, J. Sundstrom, and L. Lind The validity of a diagnosis of heart failure in a hospital discharge register Eur J Heart Fail 7 2005 787 791
22. G. Ragnarson Tennvall, J. Apelqvist, and M. Eneroth The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations J Intern Med 248 2000 397 405
23. A. Linnersjo, N. Hammar, A. Gustavsson, and C. Reuterwall Recent time trends in acute myocardial infarction in Stockholm, Sweden Int J Cardiol 76 2000 17 21
24. L.A. Johansson, and R. Westerling Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics Int J Epidemiol 29 2000 495 502
25. M. Rosén National Health Data Registers: a Nordic heritage to public health Scand J Public Health 30 2002 81 85
26. B. Wettermark, N. Hammar, and M. Fored The new Swedish prescribed drug register - opportunities for pharmacoepidemiological research and experience from the first six months Pharmacoepidemiol Drug Saf 16 2007 726 735
27. R. Marinigh, G.Y.H. Lip, and D.A. Lane Stroke prevention in atrial fibrillation patients Expert Opin Pharmacother 11 2010 2331 2350
28. L. Friberg, L. Benson, M. Rosenqvist, and G.Y. Lip Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study BMJ 344 May 30 2012 e3522
29. A.C. Carlsson, P. Wändell, U. Osby, R. Zarrinkoub, B. Wettermark, and G. Ljunggren High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health BMC Public Health 13 1 Jul 18 2013 670